Glycogen synthase kinase 3beta regulates cell death induced by synthetic triterpenoids

Roberta Venè1, Patrizia Larghero, Giuseppe Arena

  • 1Molecular Oncology and Angiogenesis Laboratory, Istituto Nazionale per la Ricerca sul Cancro (IST), Genova, Italy.

Cancer Research
|September 2, 2008
PubMed

Insights

The synthetic triterpenoid CDDO-Me induces programmed cell death in prostate cancer cells. This compound activates caspase-independent pathways and modulates glycogen synthase kinase 3beta (GSK3beta) activity, suggesting a novel therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Programmed cell death induction is a key strategy for controlling prostate cancer.
  • Synthetic oleanane triterpenoids, like CDDO-Me, show potential as chemopreventive agents.

Purpose of the Study:

  • To investigate the mechanism of cell death induced by CDDO-Me in human prostate cancer cells.
  • To explore the role of glycogen synthase kinase 3beta (GSK3beta) in CDDO-Me-mediated cytotoxicity.

Main Methods:

  • Treatment of androgen-responsive and unresponsive prostate cancer cell lines (PC3, DU145) with CDDO-Me.
  • Assays for caspase activation, poly(ADP-ribose) polymerase cleavage, DNA fragmentation, and cell viability.
  • Inhibition of caspases and GSK3beta (using inhibitors or gene silencing) to assess their role in CDDO-Me cytotoxicity.

Main Results:

  • CDDO-Me induced apoptosis markers (caspase activation, DNA fragmentation) and reduced cell viability in prostate cancer cells.
  • Caspase inhibition did not fully rescue cell death, indicating caspase-independent mechanisms.
  • CDDO-Me induced inactivating phosphorylation of GSK3beta, and GSK3 inhibition sensitized cells to CDDO-Me.

Conclusions:

  • CDDO-Me effectively induces cell death in prostate cancer cells through both caspase-dependent and -independent pathways.
  • Modulation of GSK3beta activity is implicated in the cytotoxic effects of CDDO-Me.
  • CDDO-Me represents a promising therapeutic agent for prostate cancer, potentially by targeting GSK3beta.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...